公开(公告)号：US20070113096A1

公开(公告)日：2007-05-17

申请号：US11381951

申请日：2006-05-05

Applicant: Bin Zhu ,  Xiaoming Wang ,  Shipeng Li

Inventor： Bin Zhu ,  Xiaoming Wang ,  Shipeng Li

IPC: H04L9/00

CPC classification number: H04L67/104 ,  H04L9/3236 ,  H04L9/3263 ,  H04L63/0407 ,  H04L63/0823 ,  H04L2209/603 ,  H04L2209/80

Abstract: In a peer-to-peer environment, copyrights and users' privacies can be protected by a tracking mechanism. In described implementations, tracking mechanisms can use certificates that are produced using random numbers to protect the privacy of users and/or certificates that are produced responsive to at least one hardware identifier to enable uploader to be identified to protect copyrights.

Abstract translation: 在对等环境中，版权和用户的隐私可以通过跟踪机制来保护。 在所描述的实现中，跟踪机制可以使用使用随机数产生的证书来保护响应于至少一个硬件标识符产生的用户和/或证书的隐私，以使上载者被识别以保护版权。

公开(公告)号：US20050250713A1

公开(公告)日：2005-11-10

申请号：US11114502

申请日：2005-04-26

Applicant: Bin Zhu ,  Brett Marinelli ,  Mark Macielag

Inventor： Bin Zhu ,  Brett Marinelli ,  Mark Macielag

IPC: A61K31/7048 ,  C07H17/00 ,  C07H17/08

CPC classification number: C07H17/08

Abstract: The present invention is directed to novel macrolide antibacterial agents and processes for preparing them. The present invention is further directed to pharmaceutical compositions containing the novel macrolide antibacterial agents disclosed herein and their use in the treatment and prevention of bacterial infections.

Abstract translation: 本发明涉及新型大环内酯类抗菌剂及其制备方法。 本发明进一步涉及含有本文所公开的新型大环内酯抗菌剂及其在治疗和预防细菌感染中的用途的药物组合物。

公开(公告)号：US20050080746A1

公开(公告)日：2005-04-14

申请号：US10685234

申请日：2003-10-14

Applicant: Bin Zhu ,  Guofei Gu ,  Shipeng Li

Inventor： Bin Zhu ,  Guofei Gu ,  Shipeng Li

IPC: G06F15/00 ,  G06F21/00 ,  G06F21/10 ,  G06F21/62 ,  G06Q30/06 ,  G06Q50/10 ,  G06Q99/00 ,  G09C1/00 ,  H04L9/08 ,  H04L29/08 ,  G06F17/60

CPC classification number: H04L67/104 ,  G06F21/10 ,  G06F2221/0753 ,  G06F2221/0784 ,  H04L63/10 ,  H04L69/329

Abstract: A public licensing infrastructure (PLI) for a digital rights management (DRM) system is described. In an implementation, a method includes generating a formal license for content. The formal license includes a decryption key for decrypting the content and access rules for accessing the content. A plurality of license authorities is configured to provide a plurality of partial licenses. The plurality of partial licenses is combinable to form the formal license. Each license authority provides a respective partial license.

Abstract translation: 描述了数字版权管理（DRM）系统的公共许可基础设施（PLI）。 在实现中，一种方法包括生成内容的正式许可证。 正式许可证包括用于解密内容的解密密钥和用于访问内容的访问规则。 多个许可机构被配置为提供多个部分许可证。 多个部分许可证可组合形成正式许可证。 每个许可证机构都提供相应的部分许可证。

公开(公告)号：US06226387B1

公开(公告)日：2001-05-01

申请号：US08921931

申请日：1997-08-27

Applicant: Ahmed H. Tewfik ,  Mitchell D. Swanson ,  Bin Zhu

Inventor： Ahmed H. Tewfik ,  Mitchell D. Swanson ,  Bin Zhu

IPC: G06K900

CPC classification number: G06T1/0085 ,  G06T1/0028 ,  G06T2201/0051 ,  G06T2201/0052 ,  G06T2201/0061 ,  G06T2201/0202 ,  H04N1/32154 ,  H04N1/3217 ,  H04N1/32192 ,  H04N19/117 ,  H04N19/132 ,  H04N19/154 ,  H04N19/172 ,  H04N19/176 ,  H04N19/179 ,  H04N19/63 ,  H04N21/23892 ,  H04N21/8358

Abstract: A method and apparatus for the scene-based watermarking of video data is disclosed. In one embodiment, each of a number of frames of a scene of video host data undergoes a temporal wavelet transform, from which blocks are extracted. The blocks undergo perceptual masking in the frequency domain, such that a watermark is embedded therein. Once the watermark block is taken out of the frequency domain, a spatial mask of the original block is weighted to the watermark block, and added to the original block to obtain the watermarked block.

Abstract translation: 公开了一种用于视频数据的基于场景的水印的方法和装置。 在一个实施例中，视频主机数据的场景的多个帧中的每一个经历时间小波变换，从中提取块。 这些块在频域中进行感知掩蔽，使得嵌入水印。 一旦将水印块从频域中取出，将原始块的空间掩码加权到水印块，并将其加到原始块中以获得水印块。

公开(公告)号：US11655216B2

公开(公告)日：2023-05-23

申请号：US16341595

申请日：2017-10-09

Applicant: Merck Sharp & Dohme Corp. ,  Michael T. Rudd ,  Zhaoyang Meng ,  Jenny Wai ,  David Jonathan Bennett ,  Edward J. Brnardic ,  Nigel J. Liverton ,  Shawn J. Stachel ,  Yongxin Han ,  Paul Tempest ,  Jiuxiang Zhu ,  Xuewang Xu ,  Bin Zhu

Inventor： Michael T. Rudd ,  Zhaoyang Meng ,  Jenny Wai ,  David Jonathan Bennett ,  Edward J. Brnardic ,  Nigel J. Liverton ,  Shawn J. Stachel ,  Yongxin Han ,  Paul Tempest ,  Jiuxiang Zhu ,  Xuewang Xu ,  Bin Zhu

IPC: C07D221/20 ,  C07D401/12 ,  C07D417/12 ,  C07D405/12 ,  C07D211/22 ,  C07D401/14 ,  C07D417/14

CPC classification number: C07D221/20 ,  C07D211/22 ,  C07D401/12 ,  C07D401/14 ,  C07D405/12 ,  C07D417/12 ,  C07D417/14

Abstract: In its many embodiments, the present invention provides certain substituted aryl and heteroaryl ether compounds of the Formula (I): and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, L, R4, L1, Q, and R5 are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

公开(公告)号：US10894775B2

公开(公告)日：2021-01-19

申请号：US16341591

申请日：2017-10-09

Applicant: Merck Sharp & Dohme Corp. ,  Michael T. Rudd ,  Zhaoyang Meng ,  Jenny Wai ,  David Jonathan Bennett ,  Edward J. Brnardic ,  Nigel J. Liverton ,  Shawn J. Stachel ,  Yongxin Han ,  Paul Tempest ,  Jiuxiang Zhu ,  Xuewang Xu ,  Bin Zhu ,  Chuanman Huang

Inventor： Michael T. Rudd ,  Zhaoyang Meng ,  Jenny Wai ,  David Jonathan Bennett ,  Edward J. Brnardic ,  Nigel J. Liverton ,  Shawn J. Stachel ,  Yongxin Han ,  Paul Tempest ,  Jiuxiang Zhu ,  Xuewang Xu ,  Bin Zhu ,  Chuanman Huang

IPC: C07D221/20 ,  C07D211/16 ,  C07D211/96

Abstract: In its many embodiments, the present invention provides certain piperidine compounds of the Formula (I): and pharmaceutically acceptable salts thereof, wherein X, Y, R1, R2, R3, L, R4, L1, Q, and R5 are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

公开(公告)号：US09754518B2

公开(公告)日：2017-09-05

申请号：US15219951

申请日：2016-07-26

Applicant: Jorge Perez-Bravo ,  Qinghua Xiao ,  Bin Zhu

Inventor： Jorge Perez-Bravo ,  Qinghua Xiao ,  Bin Zhu

IPC: F21V21/22 ,  F21V21/30 ,  F21V21/02 ,  F21V21/096 ,  G09F13/00 ,  G09F13/04 ,  G09F9/30 ,  G09F7/18 ,  G09F15/00 ,  G09F7/20 ,  F21S8/00 ,  F21V21/34 ,  G09F9/302 ,  F21Y105/00 ,  G09F19/22

CPC classification number: G09F9/3026 ,  F21S8/033 ,  F21S8/036 ,  F21V21/02 ,  F21V21/096 ,  F21V21/22 ,  F21V21/30 ,  F21V21/34 ,  F21Y2105/00 ,  G09F7/18 ,  G09F7/20 ,  G09F9/301 ,  G09F13/00 ,  G09F13/04 ,  G09F19/226 ,  G09F2007/1852 ,  Y10T29/49826 ,  Y10T29/4984

Abstract: Display module mounting apparatus and methods provide mounting features enabling ease of installation and service. The apparatus may have one or more releasable frame couplers and pivoting releasable frame couplers coupled to a display module having a display plane defined in relation to a substrate. One or more adjustable linkages may adjustably define a standoff distance between the display plane and a support frame to which the module may be mounted by the mounting apparatus. Concave and convex adjustments to the display plane may be made. Operation of pivoting action to tilt the display plane enables installation, removal, and serviceability of large displays constructed with a tiled plurality of display modules.

公开(公告)号：US09279573B1

公开(公告)日：2016-03-08

申请号：US14865937

申请日：2015-09-25

Applicant: Jorge Perez-Bravo ,  Qinghua Xiao ,  Bin Zhu

Inventor： Jorge Perez-Bravo ,  Qinghua Xiao ,  Bin Zhu

IPC: G09F7/20 ,  F21V21/30 ,  F21V21/096 ,  F21V21/02 ,  G09F9/302 ,  F21S8/00

CPC classification number: G09F9/3026 ,  F21S8/033 ,  F21S8/036 ,  F21V21/02 ,  F21V21/096 ,  F21V21/22 ,  F21V21/30 ,  F21V21/34 ,  F21Y2105/00 ,  G09F7/18 ,  G09F7/20 ,  G09F9/301 ,  G09F13/00 ,  G09F13/04 ,  G09F19/226 ,  G09F2007/1852 ,  Y10T29/49826 ,  Y10T29/4984

Abstract: Display module mounting apparatus and methods provide mounting features enabling ease of installation and service. The apparatus may have one or more releasable frame couplers and pivoting releasable frame couplers coupled to a display module having a display plane defined in relation to a substrate. One or more adjustable linkages may adjustably define a standoff distance between the display plane and a support frame to which the module may be mounted by the mounting apparatus. Concave and convex adjustments to the display plane may be made. Operation of pivoting action to tilt the display plane enables installation, removal, and serviceability of large displays constructed with a tiled plurality of display modules.

Abstract translation: 显示模块安装装置和方法提供安装特征，使安装和维修变得容易。 该装置可以具有一个或多个可释放的框架耦合器和枢转的可释放的框架耦合器，其耦合到具有相对于衬底限定的显示平面的显示模块。 一个或多个可调节联动装置可以可调整地限定显示平面与支撑框架之间的间隔距离，该模块可由该安装装置安装到支撑框架上。 可以对显示平面进行凹凸调整。 使显示平面倾斜的枢转动作的操作使得能够利用平铺的多个显示模块构建的大型显示器的安装，移除和可使用性。

公开(公告)号：US08653099B2

公开(公告)日：2014-02-18

申请号：US12539277

申请日：2009-08-11

Applicant: Raymond W. Colburn ,  Scott L. Dax ,  Christopher M. Flores ,  Donald W. Ludovici ,  Mingde Xia ,  Xiaoqing Xu ,  Mark A. Youngman ,  Bin Zhu

Inventor： Raymond W. Colburn ,  Scott L. Dax ,  Christopher M. Flores ,  Donald W. Ludovici ,  Mingde Xia ,  Xiaoqing Xu ,  Mark A. Youngman ,  Bin Zhu

IPC: C07D217/22 ,  C07D215/16 ,  A61K31/47

CPC classification number: C07D217/04 ,  C07C237/20 ,  C07C2102/08 ,  C07C2602/08 ,  C07D215/38 ,  C07D217/02 ,  C07D401/12

Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein A, L, R1, R2, R4 and R5 are defined herein.

Abstract translation: 公开了用于治疗各种疾病，综合征，病症和障碍（包括疼痛）的化合物，组合物和方法。 这样的化合物由式（I）表示如下：其中A，L，R 1，R 2，R 4和R 5在本文中定义。

公开(公告)号：US08637498B2

公开(公告)日：2014-01-28

申请号：US13246232

申请日：2011-09-27

Applicant: Peter J. Connolly ,  Mark J. Macielag ,  Mark E. McDonnell ,  Bin Zhu

Inventor： Peter J. Connolly ,  Mark J. Macielag ,  Mark E. McDonnell ,  Bin Zhu

IPC: A61K31/496 ,  A61K31/506 ,  A61K31/551 ,  C07D403/04 ,  C07D403/14 ,  C07D409/14 ,  C07D417/14

CPC classification number: C07D403/14 ,  C07D403/04 ,  C07D409/14 ,  C07D417/14

Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (Ia) and Formula (Ib) as follows: wherein Y, Z, and n are defined herein; and wherein Yb and Zb are as defined herein.

Abstract translation: 公开了用于治疗各种疾病，综合征，病症和障碍（包括疼痛）的化合物，组合物和方法。 这样的化合物和对映体，非对映异构体及其药学上可接受的盐由式（Ia）和式（Ib）表示如下：其中Y，Z和n如本文所定义; 并且其中Yb和Zb如本文所定义。